Avelumab for the treatment of metastatic Merkel cell carcinoma.
L.M. Cordes, J.L. Gulley
págs. 377-384
Bezlotoxumab for the treatment of Clostridium difficile-associated diarrhea.
Ritesh P. Thakare, Arunava Dasgupta, Sidharth Chopra
págs. 385-392
Keratitis in association with herpes zoster and varicella vaccines.
A. Grillo, Frederick W. Fraunfelder
págs. 393-398
Checkpoint inhibitors: a cutting edge in oncology.
Charlotte Jago
págs. 399-404
American Diabetes Association - 77th Scientific Sessions (June 9-13, 2017 - San Diego, California, USA).
S. C. Lam
págs. 405-414
New product intros (avelumab, crisaborole, deutetrabenazine, durvalumab, follitropin delta, forodesine hydrochloride (first-in-class), naldemedine tosilate, oxymetazoline hydrochloride (new indication).
págs. 415-417
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: